Skip To Main Content

Search

For optimal search results, please limit to 2 product keywords

If you are searching for information related to a product:

  • For optimal results, please enter at least 2 search terms in addition to product name
  • Example: [product name] [search term] [search term]
  • Example: Product + clinical trials
  • For an exact match, please include search terms in double quotations. For example: "health equity"

PiaSky (crovalimab-akkz)

Hands shaking over contract icon

Learn more about PiaSky

The information in this section may include content beyond what is in the FDA-approved label. Because the FDA has not approved such content, no conclusions regarding safety or efficacy may be made. Providing this information should not be construed as recommendation for use of a Genentech product for unapproved uses. For FDA-approved products please consult the product’s full prescribing information for a complete discussion of risks and benefits of the product(s) for its approved indication(s).

WARNING: SERIOUS MENINGOCOCCAL INFECTIONS
See full prescribing information for complete boxed warning

PIASKY increases the risk of serious and life-threatening infections caused by Neisseria meningitidis.
PIASKY is available only through a restricted program under a Risk Evaluation and Mitigation Strategy called the PIASKY REMS. Healthcare providers and specialty pharmacies, who prescribe or dispense PiaSky must enroll in the PIASKY REMS. Further information is available at the PIASKY website (www.PiaSkyREMS.com) or 866-469-7599.

To view a PDF of the above document, please click here.

Looking for more information?

Reach out to a Genentech Medical Science Liaison near you, or connect with the contact center.

Call Us: 1-800-821-8590 Hours: Monday-Friday, 5am-5pm PT

Publications icon

Publications and Congresses

The information in this section may include content beyond what is in the FDA-approved label. Because the FDA has not approved such content, no conclusions regarding safety or efficacy may be made. Providing this information should not be construed as recommendation for use of a Genentech product for unapproved uses. For FDA-approved products please consult the product’s full prescribing information for a complete discussion of risks and benefits of the product(s) for its approved indication(s).

Publications: The list of publications is not an exhaustive list of published materials on the product. The list of references by data topics is selected per evidence-based medicine criteria. To browse a full listing of published scientific literature:

Congresses: The list of congresses is a subset of Roche/Genentech posters and oral presentations for the product with data presented at scientific meetings in the recent 24 months. To browse full Roche/Genentech congress presentations and posters:


Filters

Crovalimab Data Topics

Showing 14 out of 14 results

No results

Try resetting the filters or selecting another category.

Looking for more information?

Reach out to a Genentech Medical Science Liaison near you, or connect with the contact center.

Call Us: 1-800-821-8590 Hours: Monday-Friday, 5am-5pm PT